Defense Secretary Pete Hegseth halted gender-affirming care for troops while pushing testosterone tests for “warfighters,” sharpening a policy fight that courts are now upholding.
Story Snapshot
- Hegseth paused gender-affirming medical procedures and new accessions with gender dysphoria.
- A federal appeals panel kept the policy in place; one judge issued a sharp dissent.
- Adam Schiff blasted Hegseth’s leadership, but his cited report addresses a different issue.
- The White House framed the policy as a readiness push under a standing executive order.
What the new Pentagon policy does right now
Defense Secretary Pete Hegseth ordered an immediate pause on all unscheduled, scheduled, or planned gender-affirming medical procedures for service members. The memo also paused new accessions for people with a history of gender dysphoria. Reporting and the department’s statements describe a reinstated ban and guidance to block future enlistment or reentry for affected individuals. These moves mark a sharp shift from prior policy and took effect at once, changing care and entry rules across the force.
The department paired this policy with a broader readiness message. Leaders said medical constraints linked to gender dysphoria are incompatible with high military standards and that service members must meet sex-based rules. Hegseth also announced warfighter fitness steps that include more frequent testing and daily training across active units. Together, these actions aim to show a single focus: improve performance and reduce risk in demanding missions.
How the courts and critics are shaping the fight
A three-judge appeals panel allowed the policy to stand, dissolving a lower court’s block while litigation continues. Two judges appointed by President Donald Trump formed the majority. A dissenting judge called the policy “gratuitously demeaning” and “openly hostile” toward transgender Americans, underscoring deep legal and moral divides over the ban. The ruling keeps the Pentagon’s approach in place for now and signals momentum for the administration’s legal stance.
Senator Adam Schiff condemned Hegseth’s leadership on national television and urged his removal, citing a Pentagon Inspector General review often called “Signalgate.” Schiff argued Hegseth put pilots at risk. But that report concerns flight safety and testosterone and does not evaluate the gender-affirming care pause. That gap weakens a direct link between Schiff’s charge and this specific policy, even as his larger critique of leadership remains sharp.
The readiness rationale and the testosterone twist
The White House grounded the military policy in an executive order named Prioritizing Military Excellence and Readiness. It directed updates to medical standards and backed the department’s claim that gender dysphoria limits conflict with service demands. The Pentagon then issued public guidance stating that service members must meet standards based on their sex and that gender dysphoria is incompatible with service requirements. These documents frame the ban as a safety and performance measure, not a culture war move.
Faith Miller, DCNF Democrats have likened Secretary of War Pete Hegseth’s new program for screening troops for testosterone deficiencies to “gender-affirming care.” Hegseth announced on Wednesday a program that will screen warfighters 30 and older annually for testosterone…
— Common Sense with Chad Law (@chadparkerlaw) July 16, 2026
At the same time, Hegseth advanced testosterone screening for fighters over age 30 and promoted optional testosterone replacement to boost performance. Critics say that effort highlights a double standard on “gender care,” since one hormone pathway is welcomed while another is paused. Supporters respond that the screening targets age-related decline tied to combat tasks, not identity. This contrast fuels claims of mixed priorities and invites scrutiny of the readiness logic behind both steps.
Why this matters beyond today’s headlines
This clash repeats a years-long cycle: one administration opens service, the next restricts it, courts weigh in, and troops in the middle ride policy whiplash. Each switch brings new rules for care, waivers, and enlistment, while leaders on both sides insist they are protecting the force. The cost is trust. Service members and families see politics drive medical decisions and careers. Many Americans read that as one more sign that powerful people play games while regular people pay the price.
What we know, and what we do not
We know Hegseth’s memo paused gender-affirming procedures and accessions and that an appeals panel kept the policy in place. We also know Schiff attacked Hegseth’s leadership using a report about pilot safety, not this care policy. What we do not have in public view is a data-rich Pentagon study tying gender-affirming care to lower readiness, or a government report measuring harm from the pause. Those facts would help answer urgent questions about health and mission risk.
Sources:
twitchy.com, abcnews.com, youtube.com, advocate.com, politico.com, usar.army.mil
